Pericarditis and chronic inflammatory demyelinating polyneuropathy during therapy with pegylated interferon alfa-2a for chronic hepatitis C

World Journal of Hepatology

Volumn 2, Issue 9, 2010, Pages 358-361

  Nishio, Kazuaki ^a   Konndo, Takeshi ^a   Okada, Shunichi ^b   Enchi, Machiko ^c  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Toyoko Hospital   (Japan)

^c Kawasaki Social Insurance Hospital   (Japan)

Author keywords

Chronic hepatitis C; Chronic inflammatory demyelinating polyneuropathy; Peginterferon alfa 2a; Pericarditis

Indexed keywords

EID: 79954635139     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v2.i9.358     Document Type: Article

References (27)

1. Boonen A, Stockbrügger RW, van der Linden S. Pericarditis after therapy with interferon-alpha for chronic hepatitis C. Clin Rheumatol 1999; 18: 177-179
2. Wisniewski B, Denis J, Fischer D, Labayle D. [Pericarditis secondary to interferon alpha in chronic hepatitis C]. Gastroenterol Clin Biol 2004; 28: 315-316
3. Gressens B, Gohy P. Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C. Acta Gastroenterol Belg 2004; 67: 301-302
4. Benjamini O, Kimhi O, Lishner M. Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha- 2b. Isr Med Assoc J 2007; 9: 486-487
5. Hamdani I, Kochlef A, Belhadj N, Kharrat J, Ghorbel A. [Acute pericardite which has occurred during the treatment of chronic hepatitis C by the interferon alpha2A]. Tunis Med 2008; 86: 404-405
6. Marzo ME, Tintoré M, Fabregues O, Montalbán X, Codina A. Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-alpha. J Neurol Neurosurg Psychiatry 1998; 65: 604
7. Khiani V, Kelly T, Shibli A, Jensen D, Mohanty SR. Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection. World J Gastroenterol 2008; 14: 318-321
8. Hirotani M, Nakano H, Ura S, Yoshida K, Niino M, Yabe I, Sasaki H. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha. Intern Med 2009; 48: 373-375
9. Kato-Motozaki Y, Komai K, Takahashi K, Ishida C, Ueda M, Kusunoki S, Yamada M. Polyethylene glycol interferon alpha- 2b-induced immune-mediated polyradiculoneuropathy. Intern Med 2009; 48: 569-572
10. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52
11. Mansat-Krzyzanowska E, Dréno B, Chiffoleau A, Litoux P. [Cardiovascular manifestations associated with interferon alfa-2A]. Ann Med Interne (Paris) 1991; 142: 576-581
12. Teragawa H, Hondo T, Amano H, Hino F, Ohbayashi M. Adverse effects of interferon on the cardiovascular system in patients with chronic hepatitis C. Jpn Heart J 1996; 37: 905-915
13. Matsumori A. Hepatitis C virus infection and cardiomyopathies. Circ Res 2005; 96: 144-147
14. McMurray RW, Elbourne K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997; 26: 689-701
15. Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, Nishioji K, Katagishi T, Nakagawa Y, Tada H, Sawa Y, Mizuno M, Kagawa K, Kashima K. Side effects of highdose interferon therapy for chronic hepatitis C. J Hepatol 1996; 25: 283-291
16. Chung YH, Shong YK. Development of thyroid autoimmunity after administration of recombinant human interferon- alpha 2b for chronic viral hepatitis. Am J Gastroenterol 1993; 88: 244-247
17. Téllez-Zenteno JF, Negrete-Pulido O, Nuñez M, Estañol-Vidal B, García-Ramos G. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature]. Rev Neurol 2002; 35: 644-646
18. Emir S, Kutluk T, Chan KW, Yalçin B, Varli K, Büyükpamukçu M. Peripheral neuropathy during alpha-interferon therapy in a child with Hodgkin's disease. Pediatr Hematol Oncol 1999; 16: 557-560
19. Lapinski TW, Nowacka B, Michalewicz M. [The peripheral polyneuropathy in patients with chronic HCV infection treated peginterferon alfa with ribavirin]. Pol Merkur Lekarski 2005; 18: 431-432
20. Marey-López J, Sousa CP. Trigeminal sensory neuropathy related to interferon-alpha treatment. Muscle Nerve 2006; 33: 581-582
21. Irioka T, Yamada M, Yamawaki M, Saito Y, Mizusawa H, Yamada M, Miura H. Acute autonomic and sensory neuropathy after interferon alpha-2b therapy for chronic hepatitis C. J Neurol Neurosurg Psychiatry 2001; 70: 408-410
22. Hoare M, Woodall T, Alexander GJ. Bell's palsy associated with IFN-alpha and ribavirin therapy for hepatitis C virus infection. J Interferon Cytokine Res 2005; 25: 174-176
23. Meriggioli MN, Rowin J. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha. Muscle Nerve 2000; 23: 433-435
24. Lin W, Harding HP, Ron D, Popko B. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gamma. J Cell Biol 2005; 169: 603-612
25. Lin W, Kemper A, Dupree JL, Harding HP, Ron D, Popko B. Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain 2006; 129: 1306-1318
26. Hughes RA. Management of chronic inflammatory demyelinating polyradiculoneuropathy. Drugs 2003; 63: 275-287
27. van Doorn PA, Ruts L. Treatment of chronic inflammatory demyelinating polyneuropathy. Curr Opin Neurol 2004; 17: 607-613